Eric Angevin
Inserm · 281 works · 13,154 citations · h-index 45
Top works
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
- Malignant effusions and immunogenic tumour-derived exosomes
- Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
- Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects
- Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection
- Exosomes as a Tumor Vaccine: Enhancing Potency Through Direct Loading of Antigenic Peptides
- Tumor-derived exosomes: a new source of tumor rejection antigens
- Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
- Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)
- Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma
- Phase II trial of thalidomide in renal-cell carcinoma
- Exosome-based immunotherapy
- Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition
- Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma
- Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma
- Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy.
- Analysis of T-cell immune response in renal cell carcinoma: Polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity